The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant therapy in advanced melanoma.
 
Shalana O'Brien
No Relationships to Disclose
 
Jimson Dsouza
No Relationships to Disclose
 
Shirly Shohat
No Relationships to Disclose
 
Neha Goel
No Relationships to Disclose
 
Sanjay S. Reddy
No Relationships to Disclose
 
Anthony J. Olszanski
Consulting or Advisory Role - Bristol-Myers Squibb; G1 Therapeutics; Merck; Takeda
Research Funding - Advaxis (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ignyta (Inst); Immunocore (Inst); Incyte (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Sujana Movva
Research Funding - Novartis (Inst); Takeda (Inst)
 
Hong Wu
No Relationships to Disclose
 
Jian Qin Yu
No Relationships to Disclose
 
Miriam Lango
No Relationships to Disclose
 
Jeffrey M. Farma
Consulting or Advisory Role - Amgen; Castle Biosciences